This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Clinical

18
Survival results from carfilzomib Phase III head-to-head trial published
Survival results from carfilzomib Phase III head-to-head trial published
Read more
Management of acute bronchiolitis
Management of acute bronchiolitis
Read more
A standalone breast screening modality
Read more
Ensuring safety in nuclear medicine
Read more
Radiological treatments for uterine fibroids
Read more
Portable ultrasound technology
Read more
Locoregional therapy of liver tumours
Read more
Vascular plugs in different clinical settings
Read more
Personalising therapies in primary osteoporosis
Read more
HCV genotyping by next generation sequencing
Read more
North West trusts take ‘giant leap’ in connecting diagnostics across hospitals
Read more
Component resolved diagnostics in allergology
Read more
Update on good risk acute myeloid leukaemia
Read more
Targeted therapies in CD30+ malignancies
Read more
Preventing exposure to cytotoxic drugs
Read more
Adding value to the healthcare system
Read more
Liquid biopsies in clinical practice
Read more
Foreword
Read more

Popular articles

Redefining management of uveal melanoma liver metastases: what oncologists need to know
Diagnostic AI tool ‘more accurate’ than physicians aims to ‘reshape’ healthcare
Be alert to Guillain-Barré risk after RSV vaccination in older adults, says MHRA
Forgo radioiodine ablation after thyroidectomy in low-risk cancer patients, say researchers
P2Y12 inhibitor monotherapy has lower MACCE risk than aspirin after PCI, study finds



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x